With H1 performance supporting its unchanged 2026 guidance, the company enters the second half with continued momentum across nutrition, health and beauty markets.
The expansion follows the successful commissioning of the Richmond facility, which became fully operational in 2025 and represents a major investment in the region’s grain-processing infrastructure.
The blend is positioned as a cost-effective alternative to traditional chemical improvers and emulsifiers, helping bakers transition to bromate-free production without sacrificing handling, consistency or product quality.
With improved first-half EBITA and strengthened leadership in the United States and Brazil, the company enters the second half of 2026 focused on operational execution, customer relationships, and continued expansion across specialty chemicals and ingredients markets.
Brenntag attributed the performance to coordinated pricing strategies and effective stocking decisions in North America and Europe, the Middle East and Africa.